Medicare's national coverage decisions for technologies, 1999-2007
- PMID: 18997221
- DOI: 10.1377/hlthaff.27.6.1620
Medicare's national coverage decisions for technologies, 1999-2007
Abstract
An analysis of Medicare national coverage decisions (NCDs) from 1999 through 2007 reveals that the Centers for Medicare and Medicaid Services (CMS) considers the available evidence as no better than fair for most of the technologies considered. Still, the CMS issues favorable decisions in 60 percent of the cases it takes on, although almost always with conditions placed on coverage. Since enactment of the 2003 Medicare Modernization Act, which legislated maximum review times for NCDs, the CMS has eliminated "long duration" decisions (more than one year) and has issued several "coverage with evidence development" decisions, which promise flexibility but also carry implementation challenges.
Similar articles
-
Medicare's national coverage decisions, 1999-2003: quality of evidence and review times.Health Aff (Millwood). 2005 Jan-Feb;24(1):243-54. doi: 10.1377/hlthaff.24.1.243. Health Aff (Millwood). 2005. PMID: 15647237
-
Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits.Acad Radiol. 2012 Sep;19(9):1060-5. doi: 10.1016/j.acra.2012.05.005. Epub 2012 Jun 29. Acad Radiol. 2012. PMID: 22748382
-
Coverage options for promising technologies: Medicare's 'coverage with evidence development'.Health Aff (Millwood). 2006 Sep-Oct;25(5):1218-30. doi: 10.1377/hlthaff.25.5.1218. Health Aff (Millwood). 2006. PMID: 16966717
-
Value-based interventional pain management: a review of medicare national and local coverage determination policies.Pain Physician. 2013 May-Jun;16(3):E145-80. Pain Physician. 2013. PMID: 23703416 Review.
-
Medicare reimbursement for physician services: the current status of local payment policy.J Am Coll Radiol. 2005 Nov;2(11):896-905. doi: 10.1016/j.jacr.2005.05.012. J Am Coll Radiol. 2005. PMID: 17411963 Review.
Cited by
-
Evaluation of technologies approved for supplemental payments in the United States.BMJ. 2019 Jun 17;365:l2190. doi: 10.1136/bmj.l2190. BMJ. 2019. PMID: 31209124 Free PMC article. Review.
-
Paying for Frequent Dialysis.Am J Kidney Dis. 2019 Aug;74(2):248-255. doi: 10.1053/j.ajkd.2019.01.027. Epub 2019 Mar 25. Am J Kidney Dis. 2019. PMID: 30922595 Free PMC article.
-
Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study.Medicine (Baltimore). 2018 Oct;97(40):e12715. doi: 10.1097/MD.0000000000012715. Medicine (Baltimore). 2018. PMID: 30290675 Free PMC article.
-
Performance-Based Risk-Sharing Arrangements: An Updated International Review.Pharmacoeconomics. 2017 Oct;35(10):1063-1072. doi: 10.1007/s40273-017-0535-z. Pharmacoeconomics. 2017. PMID: 28695544 Review.
-
Persistent Variation in Medicare Payment Authorization for Home Hemodialysis Treatments.Health Serv Res. 2018 Apr;53(2):649-670. doi: 10.1111/1475-6773.12650. Epub 2017 Jan 19. Health Serv Res. 2018. PMID: 28105639 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
